Examines the pathophysiological consequences of hyperphosphatemia in end-stage renal disease patients. Effect of elevated calcium and phosphorous products on risk of mortality; Factors affecting the development of secondary hyperparathyroidism, soft tissue calcification and calciphylaxis; Interference in the calcitriol therapy.